Covered recipient · General Payments record
WILLIAM ALBERT STILES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$240.28
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $203.40 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $65.06 | 3 |
| Ultragenyx Pharmaceutical Inc. | $46.23 | 2 |
| Veloxis Pharmaceuticals, Inc. | $33.78 | 1 |
| Amgen Inc. | $25.34 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.80 | 1 |
| Lilly USA, LLC | $14.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $25.34 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117693346 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.80 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086367125 | CMS |
| Lilly USA, LLC | $14.19 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135989878 | CMS |
| Novo Nordisk Inc | $21.76 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100281100 | CMS |
| Novo Nordisk Inc | $23.94 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100229014 | CMS |
| Novo Nordisk Inc | $19.36 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100633859 | CMS |
| Ultragenyx Pharmaceutical Inc. | $26.44 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153285803 | CMS |
| Ultragenyx Pharmaceutical Inc. | $19.79 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153283405 | CMS |
| Veloxis Pharmaceuticals, Inc. | $33.78 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147094465 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.